FT NYSE Arca Biotechnology UE A/ IE00BL0L0H60 /
| NAV9/28/2023 | Chg.-0.1240 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 17.8980USD | -0.69% | reinvestment | Equity Worldwide | First Trust Advisors ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | - | - | 1.42 | -1.12 | -3.19 | -2.15 | -2.79 | 5.56 | 4.23 | - |
| 2021 | 4.23 | -4.04 | -4.62 | 2.37 | -0.73 | 5.94 | -2.66 | 3.41 | -4.49 | -0.08 | -5.54 | 3.34 | -3.71% |
| 2022 | -8.06 | -1.63 | 1.78 | -8.94 | -0.69 | 0.53 | 3.37 | -2.77 | -3.12 | 8.59 | 8.45 | -0.68 | -4.69% |
| 2023 | 5.92 | -6.00 | 0.86 | -0.96 | -0.46 | -0.27 | 1.90 | -0.70 | -5.03 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.11% | 13.99% | 18.37% | 22.17% | -% |
| Sharpe ratio | -0.72 | -0.66 | 0.27 | -0.28 | - |
| Best month | +5.92% | +1.90% | +8.59% | +8.59% | - |
| Worst month | -6.00% | -5.03% | -6.00% | -8.94% | - |
| Maximum loss | -11.61% | -8.76% | -11.61% | -33.37% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Performance
| YTD | -5.11% | ||
|---|---|---|---|
| 6 Months | -2.71% | ||
| 1 Year | +8.90% | ||
| 3 Years | -6.48% | ||
| 5 Years | - | ||
| Since start | -10.51% | ||
| Year | |||
| 2022 | -4.69% | ||
| 2021 | -3.71% | ||